Interní Med. 2011; 13(6): 241-243

Risk factors for atherosclerosis in women

MUDr.Jan Piťha, CSc.
Laboratoř pro výzkum aterosklerózy, Institut klinické a experimentální medicíny, Praha

Atherosclerosis manifests quite often (50 % of men and 60 % of women) as sudden cardiac death in persons with no previous signs of

coronary disease. Based on current knowledge, much of atherosclerotic vascular events might be avoided. Therefore, high-risk individuals

are to be indentified and treated. Currently recommended diagnostic and therapeutic procedures are, however, mostly based

on the results of studies on the male population. However, in the general population, in women the prevalence and mortality of/from

cardiovascular diseases and mainly strokes is in absolute numbers greater than in men. Smoking and diabetes mellitus and associated

combined dyslipidemia (high level of triglycerides and lower protective HDL cholesterol) appear to be more aggressive cardiovascular

risk factor in women. Unique cardiovascular risk factors in women are sex hormones and their changes; however, the use of synthetic

hormones in the prevention of cardiovascular events in women brought largely negative results. Other specific risk factors in women are:

preeclampsia, hypertension in pregnancy and gestational diabetes mellitus. Currently, in women greater emphasis should be placed on

smoking cessation, adequate physical activity and on optimizing the lipid spectrum, including triglycerides and HDL cholesterol.

Keywords: women, atherosclerosis, cardiovascular diseases, risk factors, sex hormones

Published: June 20, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Piťha J. Risk factors for atherosclerosis in women. Interní Med. 2011;13(6):241-243.
Download citation

References

  1. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989; 9(Suppl I): I19-I32. Go to PubMed...
  2. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. J Am Coll Cardiol. 1985; 5(Suppl 6): 141B-149B. Go to original source... Go to PubMed...
  3. Vaverková H, Soška V, Rosolová H, et al. Doporučení pro diagnostiku a léčbu dyslipidemií v dospělosti, vypracované výborem České společnosti pro aterosklerózu. Vnitř Lék 2007; 53(2): 181-197. Go to PubMed...
  4. Sharma RK, Singh VN, Reddy HK. Thinking beyond lowdensity lipoprotein cholesterol: strategies to further reduce cardiovascular risk. Vasc Health Risk Manag. 2009; 5: 793-799. Go to original source... Go to PubMed...
  5. http://www.uzis.cz/article.phptype=1&mnu_id=5100&mnu_action=select
  6. Milcent C, Dormont B, Durand-Zaleski I, Steg PG. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Circulation 2007; 115(7): 833-839. Go to original source... Go to PubMed...
  7. Cífková R, Skodová Z, Bruthans J, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech postMONICA. Atherosclerosis 2010; 211(2): 676-681. Go to original source... Go to PubMed...
  8. Bairey Merz CN, Mark S, Boyan BD, et al. Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies. J Womens Health (Larchmt) 2010; 19(6): 1059-1072. Go to original source...
  9. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009, 20; 54(17): 1561-1575. Go to original source... Go to PubMed...
  10. Executive Writing Committee, Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women-2011 Update: A Guideline From the American Heart Association. Circulation 2011, 16. [Epub ahead of print].
  11. Grundtvig M, Hagen TP, German M, Reikvam A. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehabil. 2009; 16(2): 174-179. Go to original source... Go to PubMed...
  12. Barrett-Connor E, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 1991; 265: 627-631. Go to original source... Go to PubMed...
  13. Tankó LB, Bagger YZ, Qin G, et al. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005; 111(15): 1883-1890. Go to original source... Go to PubMed...
  14. McNamara JR, Shah PK, Nakajima K, et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 2001; 154(1): 229-236. Go to original source... Go to PubMed...
  15. Grady D, Herrington D, Bittner V, et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288(1): 49-57. Erratum in: JAMA 2002; 288(9): 1064. Go to original source... Go to PubMed...
  16. Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288(3): 321-333. Go to original source... Go to PubMed...
  17. Early versus Late Intervention Trial with Estradiol (ELITE). http://clinicaltrials.gov/show/NCT00114517.
  18. Kronos Early Estrogen Prevention Study (KEEPS) http://clinicaltrials.gov/show/NCT00154180.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.